Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A0003 Eye Drops 0.55% in Cystinosis Patients
jRCT2021200029Phase 3Active, not recruiting
- Sponsor
- Mylan
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cysteamine in cystinosis, sponsored by Mylan. Primary endpoint: IVCM Total Score by in vivo confocal microscopy. Started Dec 2020; status: active, not recruiting.
02
Drugs
cysteamine
03
Conditions
cystinosis
Beyond the preview
Go deeper on jRCT2021200029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2021200029.